Clinical trial
Predictive Value of HBV pgRNA on Long-term Outcomes in Hepatitis B Patients Treated With Antiviral Therapy
NCT05965388 is registered in ClinicalTrials.gov with Wen-hong Zhang as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Predictive Value of HBV pgRNA on Long-term Outcomes in Hepatitis B Patients Treated With Antiviral Therapy
- Lead sponsor
- Wen-hong Zhang
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- December 1, 2023
- Completion date
- February 1, 2029
- Enrollment
- 5,000 (estimated)
- Sites
- 10
Conditions
As the registry lists them; a condition with its own page is linked.
hbv, hcc